Matthew Keeney

Keeney MT, Hoffman EK, Farmer K, Bodle CR, Fazzari M, Zharikov A, Castro SL, Hu X, Mortimer A, Kofler JK, Cifuentes-Pagano E, Pagano PJ, Burton EA, Hastings TG, Greenamyre JT, Di Maio R. NADPH oxidase 2 activity in Parkinson's disease. Neurobiol Dis. 2022 Aug;170:105754. doi: 10.1016/j.nbd.2022.105754. Epub 2022 May 13. PMID: 35577065; PMCID: PMC9284948.

Hallacli E, Kayatekin C, Nazeen S, Wang XH, Sheinkopf Z, Sathyakumar S, Sarkar S, Jiang X, Dong X, Di Maio R, Wang W, Keeney MT, Felsky D, Sandoe J, Vahdatshoar A, Udeshi ND, Mani DR, Carr SA, Lindquist S, De Jager PL, Bartel DP, Myers CL, Greenamyre JT, Feany MB, Sunyaev SR, Chung CY, Khurana V. The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell. 2022 Jun 09;185(12):2035-2056.e33. pii: S0092-8674(22)00592-X.

Keeney MT, Hoffman EK, Farmer K, Bodle CR, Fazzari M, Zharikov A, Castro SL, Hu X, Mortimer A, Kofler JK, Cifuentes-Pagano E, Pagano PJ, Burton EA, Hastings TG, Greenamyre JT, Di Maio R. NADPH oxidase 2 activity in Parkinson's disease. Neurobiol Dis. 2022 Aug;170:105754. pii: S0969-9961(22)00146-2. Epub 2022 May 13.

Rocha EM, Keeney MT, Di Maio R, De Miranda BR, Greenamyre JT. LRRK2 and idiopathic Parkinson's disease. Trends Neurosci. 2022 Mar;45(3):224-236. pii: S0166-2236(21)00250-2. Epub 2022 Jan 04.

Keeney, M. T., Hoffman, E. K., Greenamyre, J. T. and Di Maio, R. (2021). Measurement of LRRK2 Kinase Activity by Proximity Ligation Assay. Bio-protocol 11(17): e4140. DOI: 10.21769/BioProtoc.4140.

Keeney, M.T., Hoffman E.K., Farmer, K., Bodle, C.R., Fazzari, M., Zharikov, A., Castro, S., Kofler, J., Cifuentes-Pagano, E., Pagano, P.J, Burton, E.A, Hastings, T. G., Greenamyre, J. T, & Di Maio, R. (2021). Neuronal NADPH Oxidase 2 in Parkinson’s Disease Pathogenesis. bioRxiv doi: https://doi.org/10.1101/2021.05.13.443999.

Keeney MT, Hoffman EK, Greenamyre TJ, Di Maio R. Measurement of LRRK2 Kinase Activity by Proximity Ligation Assay. Bio Protoc. 2021 Sep 05;11(17):e4140. doi: 10.21769/BioProtoc.4140. Epub 2021 Sep 05.

Rocha EM, De Miranda BR, Castro S, Drolet R, Hatcher NG, Yao L, Smith SM, Keeney MT, Di Maio R, Kofler J, Hastings TG, Greenamyre JT. LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease. Neurobiol Dis. 2020 Feb;134:104626. pii: S0969-9961(19)30301-8. Epub 2019 Oct 13.

Rocha EM, De Miranda BR, Castro S, Drolet R, Hatcher NG, Yao L, Smith SM, Keeney MT, Di Maio R, Kofler J, Hastings TG, Greenamyre JT. LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease.Neurobiol Dis. 2020 Feb;134:104626. doi: 10.1016/j.nbd.2019.104626. Epub 2019 Oct 13. PMID: 31618685 PMCID: PMC7345850

Journal Articles

Awards and Honors